|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/497 | (2013.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 47/46 | (2006.01) | ||
| A61K 9/0095 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 9/1694 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/16 | (2006.01) |
| (11) | Number of the document | 3949952 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20784888.8 |
| Date of filing the European patent application | 2020-04-02 | |
| (97) | Date of publication of the European application | 2022-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2020/015225 |
| Date | 2020-04-02 |
| (87) | Number | WO 2020/204142 |
| Date | 2020-10-08 |
| (30) | Number | Date | Country code |
| 2019070997 | 2019-04-03 | JP |
| (72) |
SASAKI Akihiko , JP
TANAKA Ko , JP
MIYAZAKI Masakazu , JP
TAKAE Seiji , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (54) | PHARMACEUTICAL COMPOSITION |
| PHARMACEUTICAL COMPOSITION |